NASDAQ:PRPH
ProPhase Labs Stock News
$5.03
-0.0800 (-1.57%)
At Close: May 17, 2024
ProPhase Labs, Inc. (PRPH) Soars 11.2%: Is Further Upside Left in the Stock?
08:17am, Tuesday, 05'th Apr 2022
ProPhase Labs, Inc. (PRPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more
ProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q4 2021 Results - Earnings Call Transcript
03:30pm, Wednesday, 30'th Mar 2022
ProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q4 2021 Results - Earnings Call Transcript
GARDEN CITY, NY, March 24, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified company offering a range of services including diagnostic testing, genomics testing and contract
ProPhase Labs declares $0.30 dividend
01:28pm, Wednesday, 16'th Feb 2022 Seeking Alpha
ProPhase Labs (NASDAQ:PRPH) declares $0.30/share special dividend.Payable March 10; for shareholders of record March 1; ex-div Feb.
ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference
08:30am, Thursday, 03'rd Feb 2022
GARDEN CITY, NY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the
ProPhase Labs Q4 2021 COVID-19 testing volumes surpass previous levels
01:52pm, Thursday, 13'th Jan 2022 Seeking Alpha
ProPhase Labs (PRPH) announces that testing volumes exceeded well over 300,000 PCR COVID-19 tests during Q4 2021
ProPhase Labs (NASDAQ:PRPH) Earns Buy Rating from Analysts at HC Wainwright
06:24am, Wednesday, 22'nd Dec 2021 Dakota Financial News
Investment analysts at HC Wainwright began coverage on shares of ProPhase Labs (NASDAQ:PRPH) in a report issued on Monday, Price Targets.com reports. The brokerage set a buy rating and a $12.00 price target on the stock. HC Wainwrights target price indicates a potential upside of 52.09% from the stocks current price. A number of other []
ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team
01:30pm, Thursday, 16'th Dec 2021 Intrado Digital Media
Precision Medicine division adds Industry Veteran Sam A. Beeler as Chief Strategy Officer; Diagnostics Division Promotes Alice Lioi and Jason Karkus to EVP and Co-Chief Operating Officers and Sergio Miralles to EVP/ Chief Information Officer
State Street Corp Invests $86,000 in ProPhase Labs, Inc. (NASDAQ:PRPH)
09:12am, Monday, 13'th Dec 2021 Transcript Daily
State Street Corp purchased a new position in shares of ProPhase Labs, Inc. (NASDAQ:PRPH) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund purchased 13,795 shares of the companys stock, valued at approximately $86,000. State Street Corp owned 0.09% of ProPhase Labs at the end of []
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Sold by Northern Trust Corp
09:06am, Monday, 06'th Dec 2021 Dakota Financial News
Northern Trust Corp trimmed its stake in ProPhase Labs, Inc. (NASDAQ:PRPH) by 42.9% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 19,850 shares of the companys stock after selling 14,939 shares during the quarter. Northern Trust Corp owned approximately 0.13% of ProPhase Labs worth []
PROPHASE LABS, INC. ANNOUNCES INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(C)(4)
09:15pm, Tuesday, 23'rd Nov 2021 Intrado Digital Media
GARDEN CITY, NY, Nov. 23, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that it has granted an inducement award to a new employee.
ProPhase Labs' (PRPH) CEO Ted Karkus on Q3 2021 Results - Earnings Call Transcript
05:00pm, Friday, 12'th Nov 2021
ProPhase Labs' (PRPH) CEO Ted Karkus on Q3 2021 Results - Earnings Call Transcript
ProPhase Labs to Present at the Q4 Investor Summit Conference
08:30am, Wednesday, 10'th Nov 2021
GARDEN CITY, NY, Nov. 10, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the
GARDEN CITY, NY, Nov. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, will hold a conference call on Friday, November 12, 2021 at 11:00 a.